DEVELOPMENT OF RADIOLIGAND THERAPY TARGETING CD46 FOR TREATMENT OF METASTATIC PROSTATE CANCER
$1,615,001FY2021Defense Health AgencyDOD
Regents Of The University Of California, San Francisco, The
Regents Of The University Of California, San Francisco, The